Skip to main
BEAT

HeartBeam (BEAT) Stock Forecast & Price Target

HeartBeam (BEAT) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

HeartBeam Inc. is positioned for significant growth in the medical technology sector, driven by its innovative Vector Electrocardiography (VECG) platform, which has shown strong equivalence to existing 12-lead systems, enhancing approval prospects and market adoption as it seeks FDA clearance for its telehealth products. The potential expansion into a $1.3 to $2.6 billion annual revenue stream targeting elevated-risk patients underscores the company's promising financial outlook, especially in light of the rapidly growing global mobile ECG devices market, projected to rise from $4.1 billion in 2024 to $8.9 billion by 2032. Additionally, the mobile healthcare devices market's anticipated growth from $155 billion in 2025 to $745.7 billion by 2035 at a 17% CAGR further demonstrates the substantial market demand for HeartBeam's solutions, positioning the company favorably within the healthcare landscape.

Bears say

HeartBeam Inc faces significant financial challenges that contribute to a negative outlook for its stock. The company may struggle with demand for its products due to potential issues surrounding reimbursement, which, coupled with a weak performance in its ECG systems, could hinder revenue generation and operational results. Furthermore, the auditors’ going-concern opinion highlights serious doubts about the company’s sustainability without new funding, indicating that prolonged negative cash flows could lead to adverse operational decisions, further pressuring the stock.

HeartBeam (BEAT) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HeartBeam and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HeartBeam (BEAT) Forecast

Analysts have given HeartBeam (BEAT) a Strong Buy based on their latest research and market trends.

According to 2 analysts, HeartBeam (BEAT) has a Strong Buy consensus rating as of Jan 11, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $6.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $6.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HeartBeam (BEAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.